Trials / Unknown
UnknownNCT00000339
Infusion Laboratory: Protocol 3 (Risperidone) - 4
Infusion Laboratory: Protocol 3 (Risperidone)
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 13 (planned)
- Sponsor
- National Institute on Drug Abuse (NIDA) · NIH
- Sex
- All
- Age
- 21 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate clinical safety issues pertaining to risperidone, to cocaine and to its interaction, and to determine how pretreatment with risperidone modifies the subjective as well as physiological effects of cocaine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Risperidone |
Timeline
- Start date
- 1996-06-01
- First posted
- 1999-09-21
- Last updated
- 2017-01-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00000339. Inclusion in this directory is not an endorsement.